10th Anniversary of the JCA-Mauvernay Award
This year in its tenth edition, the JCA-Mauvernay Award was given to two mid-career scientists, Dr. Eiji Hara (Japanese Foundation for Cancer Research) & Dr. Tatsuhiro Shibata (National Cancer Center Research Institute), during the 73rd Annual Meeting of the Japanese Cancer Association on Saturday September 27, at Pacifico Yokohama.
The JCA-Mauvernay Award was initiated by Dr. Mauvernay, founder of Switzerland’s Debiopharm. The award is given to two young japanese scientists below 50 years of age who greatly contributed in the field of oncology to basic or applied research, respectively. Debiopharm as well as Dr. Mauvernay have long lasting and strong ties to japan. This award has a total value of CHF 25’000 and it aims at recognizing outstanding achievements in the field of oncology amongst Japanese researchers, in both the fundamental and the clinical aspects.
The 10 year anniversary was celebrated at the Swiss Ambassador’s residence with the presence of most of the 17 previous recipients as well as the 2 new awardees. Most impressive were all the witty speeches of the scientists who mentioned that receiving the award did not just give their career a boost, but often they referred to the prize as the starting point of their increased recognition in the community, leading to more grants or new positions and an increased output.
The son of the founder and Executive Vice President, Mr. Thierry Mauvernay as well as Dr. Maurice Wagner of Debiopharm, and Prof. Tetsuo Noda, president of the Japan Cancer Association (JCA), organized the anniversary celebration and congratulated each previous recipient with a small gift from Switzerland.